All In Biotech

Drug Trial Radar · NCT07171983

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

A 2-Part, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986454 in Participants With Rheumatoid Arthritis

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

46

Planned (sponsor's estimate)

Start

Feb 27, 2026

Primary completion

Jun 28, 2027

Study completion Aug 25, 2027

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Sep 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis

Conditions

  • Rheumatoid Arthritis

Interventions

  • BMS-986454Drug

    Specified dose on specified days

  • PlaceboOther

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events (AEs)Time frame: Up to 6 months
  2. Number of participants with serious adverse events (SAEs)Time frame: Up to 6 months
  3. Number of participants with physical examination findingsTime frame: Up to 6 months
  4. Number of participants with vital sign measurement findingsTime frame: Up to 6 months
  5. Number of participants with 12-lead electrocardiogram (ECG) findingsTime frame: Up to 6 months
  6. Number of participants with clinical laboratory test findingsTime frame: Up to 6 months

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Nizams Institute Of Medical Sciences

    Hyderabad, Andhra Pradesh, India · Recruiting

  • Apollo Hospitals Ahmedabad

    Ahmedabad, Gujarat, India · Recruiting

  • Local Institution - 0003

    Bangalore, Karnataka, India · Not yet recruiting

  • JSS Hospital

    Mysuru, Karnataka, India · Recruiting

  • All India Institute of Medical Sciences (AIIMS) - Nagpur

    Nagpur, Maharashtra, India · Recruiting

  • Life Point Mutispecialty Hospital Pvt. Ltd.

    Pune, Maharashtra, India · Recruiting

  • Local Institution - 0007

    Bhubaneswar, Odisha, India · Completed

  • Local Institution - 0002

    Hyderabad, Telangana, India · Not yet recruiting

  • Krishna Institute of Medical Sciences Limited

    Secunderabad, Telangana, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.